TRCT
BNR

Tower Research Capital (TRC)’s Burning Rock Biotech BNR Stock Holding History

Tower Research Capital (TRC)’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452 Buy
+28
New +$733 ﹤0.01% 4869
2025
Q1 		– Sell
-192
Closed -$1.3K – 5222
2024
Q4 		$1.3K Buy
192
+14
+8% +$64 ﹤0.01% 5053
2024
Q3 		$582 Sell
178
-83
-32% -$458 ﹤0.01% 5306
2024
Q2 		$1.64K Buy
+261
New +$1.99K ﹤0.01% 5117
2023
Q4 		– Sell
-17
Closed -$169 – 5929
2023
Q3 		$169 Sell
17
-68
-80% -$1.06K ﹤0.01% 5676
2023
Q2 		$1.82K Buy
+85
New +$2.25K ﹤0.01% 5308
2023
Q1 		– Sell
-1,237
Closed -$28K – 5822
2022
Q4 		$28K Buy
1,237
+698
+129% +$15.9K ﹤0.01% 2801
2022
Q3 		$13K Sell
539
-34
-6% -$1.1K ﹤0.01% 4257
2022
Q2 		$16K Buy
573
+328
+134% +$14.6K ﹤0.01% 3999
2022
Q1 		$23K Buy
245
+222
+965% +$19.3K ﹤0.01% 3387
2021
Q4 		$2K Buy
+23
New +$3.15K ﹤0.01% 5599
2021
Q3 		– Sell
-7
Closed -$2K – 5772
2021
Q2 		$2K Buy
+7
New +$2.07K ﹤0.01% 5019

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Tower Research Capital (TRC)'s BNR Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Burning Rock Biotech (BNR) in Q1 2026: 28 shares worth $452. The stake represents ﹤0.01% of the portfolio and ranks #4869 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BNR as recently as Q4 2024.

Tower Research Capital (TRC) first reported a position in BNR in Q2 2021 and has held it in 12 quarters since. The position peaked at $28K in Q4 2022. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Tower Research Capital (TRC) held 28 shares of Burning Rock Biotech worth $452 as of Q1 2026.
  • Burning Rock Biotech was a new Tower Research Capital (TRC) position in Q1 2026.
  • Burning Rock Biotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4869 holding.
  • Tower Research Capital (TRC) first reported a position in Burning Rock Biotech in Q2 2021 and has held it in 12 quarters since.
  • Tower Research Capital (TRC)'s Burning Rock Biotech position peaked at $28K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.